Pubmed    Pubmed Central
uBio Home | uBioRSS

WebSearchLiteratureMolecularImages

 uBio  Web Results 1 - 10 of about 21

Synonyms:
   Ozola blitearia 

Broader Terms:
   Ozola 
 
 


External Resources:



1.  Occurrence of Pathogenic and Potentially Pathogenic Bacteria in Microgreens, Sprouts, and Sprouted Seeds on Retail Market in Riga, Latvia.LinkIT
Berg?pica I, Ozola A, Milti?a E, Alksne L, Meistere I, Cibrovska A, Granti?a-Ievi?a L
Foodborne pathogens and disease, 2020
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

2.  Dataset of annotated food crops and weed images for robotic computer vision control.LinkIT
Sudars K, Jasko J, Namatevs I, Ozola L, Badaukis N
Data in brief, 2020
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

3.  The complementary effect of rs1042522 in TP53 and rs1805007 in MC1R is associated with an elevated risk of cutaneous melanoma in Latvian population.LinkIT
Ozola A, Ruklisa D, Pjanova D
Oncology letters, 2019
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

4.  Peptidomimetic plasmepsin inhibitors with potent anti-malarial activity and selectivity against cathepsin D.LinkIT
Zogota R, Kinena L, Withers-Martinez C, Blackman MJ, Bobrovs R, Pantelejevs T, Kanepe-Lapsa I, Ozola V, Jaudzems K, Suna E, Jirgensons A
European journal of medicinal chemistry, 2019
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

5.  Azole-based non-peptidomimetic plasmepsin inhibitors.LinkIT
Kinena L, Leitis G, Kanepe-Lapsa I, Bobrovs R, Jaudzems K, Ozola V, Suna E, Jirgensons A
Archiv der Pharmazie, 2018
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

6.  Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.LinkIT
Radovica-Spalvina I, Latkovskis G, Silamikelis I, Fridmanis D, Elbere I, Ventins K, Ozola G, Erglis A, Klovins J
BMC medical genetics, 2015
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

7.  The lack of E318K MITF germline mutation in Latvian melanoma patients.LinkIT
Ozola A, Pjanova D
Cancer genetics, 2015
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

8.  Inherited variation in the PARP1 gene and survival from melanoma.LinkIT
Davies JR, Jewell R, Affleck P, Anic GM, Randerson-Moor J, Ozola A, Egan KM, Elliott F, García-Casado Z, Hansson J, Harland M, Höiom V, Jian G, Jönsson G, Kumar R, Nagore E, Wendt J, Olsson H, Park JY, Patel P, Pjanova D, Puig S, Schadendorf D, Sivaramakrishna Rachakonda P, Snowden H, Stratigos AJ, Bafaloukos D, Ogbah Z, Sucker A, Van den Oord JJ, Van Doorn R, Walker C, Okamoto I, Wolter P, Barrett JH, Timothy Bishop D, Newton-Bishop J
International journal of cancer, 2014
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

9.  Analysis of Latvian familial melanoma patients shows novel variants in the noncoding regions of CDKN2A and that the CDK4 mutation R24H is a founder mutation.LinkIT
Veinalde R, Ozola A, Azarjana K, Molven A, Akslen LA, Doni?a S, Proboka G, C?ma I, Baginskis A, Pjanova D
Melanoma research, 2013
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

10.  Melanoma risk associated with MC1R gene variants in Latvia and the functional analysis of rare variants.LinkIT
Ozola A, Azarjana K, Doni?a S, Proboka G, Mandrika I, Petrovska R, C?ma I, Heisele O, E??ele L, Streinerte B, Pjanova D
Cancer genetics, 2013
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0



123»